A 47-year-old man from Sturgis has been sentenced to 5 years and 10 months in prison as of Wednesday, January 8, 2025. The court found him guilty of possessing and participating in a conspiracy to sell and distribute counterfeit mental health medication, as well as other illicit drugs, through the dark web.
The U.S. Attorney’s Office for the Western District of Michigan revealed that Erik Miller collaborated with a dark web vendor to distribute fake Xanax® pills and other illicit substances, such as methamphetamine and MDMA. The counterfeit anxiety pills were skillfully crafted to resemble authentic products from Pharmacia & Upjohn, Co., a division of Pfizer, Inc.
Miller, a 47-year-old individual, was involved in the distribution of prescription drugs without the proper requirement of a prescription. He regularly received packages containing substantial amounts of Xanax® and other medications, which he proceeded to sell on behalf of the vendor. In September of 2024, Miller acknowledged his involvement in these illegal activities and pleaded guilty.
Investigators carried out search warrants at Miller’s residence and another property associated with him on April 14, 2023. During the search, they discovered various controlled substances, including methamphetamine, MDMA, cocaine, LSD, and counterfeit Xanax®. Additionally, evidence of a significant drug trafficking operation was uncovered. It was also revealed that Miller unlawfully possessed three firearms, despite being prohibited from doing so.
Counterfeit pills pose a significant risk to users due to their potential inclusion of incorrect and dangerous ingredients. This includes substances such as fentanyl or methamphetamine, which can be lethal. Although these pills may visually resemble legitimate prescription medications, individuals who consume them could be unknowingly exposing themselves to harmful or even fatal doses.
“Popping a fake pill is a game of Russian Roulette…One pill can kill,” warned U.S. Attorney, Mark Totten. “People should only take prescription medications that are prescribed by a licensed medical professional and dispensed by a licensed pharmacist. My office will continue to hold individuals accountable for distributing these dangerous substances in our communities.”
The Drug Enforcement Administration (DEA) and the United States Postal Inspection Service (USPIS) conducted an investigation into this case. Assistant U.S. Attorney Stephanie Carowan handled the prosecution.
